These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31164163)

  • 1. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
    Wang R; Li G; Zhuang G; Sun S; Song Z
    Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer.
    Han X; Du C; Chen Y; Zhong X; Wang F; Wang J; Liu C; Li M; Chen S; Li B
    Cancer Biomark; 2019; 25(4):325-332. PubMed ID: 31322549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W; Cui Y; Wang D; Wang Y; Wang L
    Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
    Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
    Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
    Li L; Mou YP; Wang YY; Wang HJ; Mou XZ
    Pathol Res Pract; 2019 Sep; 215(9):152511. PubMed ID: 31255331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
    Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
    Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.
    Kong XM; Zhang GH; Huo YK; Zhao XH; Cao DW; Guo SF; Li AM; Zhang XR
    Int J Clin Exp Pathol; 2015; 8(10):12845-52. PubMed ID: 26722475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
    He H; Liao X; Yang Q; Liu Y; Peng Y; Zhong H; Yang J; Zhang H; Yu Z; Zuo Y; Guan C; Xu Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809993. PubMed ID: 30381030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.
    Wan L; Zhu L; Xu J; Lu B; Yang Y; Liu F; Wang Z
    Cell Physiol Biochem; 2014; 34(4):1273-90. PubMed ID: 25278243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
    Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
    Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.
    Chang Y; Deng Q; Guan Z; Cheng Y; Sun Y
    Mol Biotechnol; 2022 Jan; 64(1):17-24. PubMed ID: 34431044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion.
    Sheng Y; Hu R; Zhang Y; Luo W
    Clin Exp Med; 2020 Aug; 20(3):417-425. PubMed ID: 32279128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.